TGFB1 and cancer: Inactivation of SMAD3 in cancer diminishes the antagonism of TGF-β on BMP responses and enables TGF-β to induce BRE downstream tumor promoting Id genes [137, 233, 234, 254, 265] normally suppressed by canonical TGF-β signaling [137, 306, 307].